Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

UK Launches Clinical Research Facility

Published: Friday, May 16, 2014
Last Updated: Friday, May 16, 2014
Bookmark and Share
NIHR/Wellcome King’s facility officially opened on Friday 9th May, by Chief Medical Officer Professor Dame Sally Davies.

Jointly funded by the National Institute for Health Research (NIHR) and the Wellcome Trust, the CRF is a pioneering collaboration between King’s College London, its NHS partners, King’s College Hospital, South London and Maudsley (SLaM), and Guy’s and St Thomas’ NHS Foundation Trusts, and the pharmaceutical industry to facilitate world leading research across physical and mental healthcare.

The CRF was designed specifically to support clinical trials in mental health and neurosciences, whilst also enabling pioneering research in specialist fields including haemato-oncology,cardiovascular medicine and diabetes.

Based at the Denmark Hill campus, the CRF is uniquely positioned to draw on research and treatment expertise across physical and mental healthcare. King’s College Hospital is one of London’s designated trauma centres and a world leader in the treatment of leukaemia and liver disease, whilst SLaM and the Institute of Psychiatry (IoP) at King’s College London bring unparalleled expertise in mental health and neurosciences.

Professor Dame Sally Davies said: “This facility brings research into the heart of the NHS. We are realising our vision, set out ten years ago, about what can we achieve if we bring clinical and academic expertise together. Today celebrates partnerships. The CRF is a partnership between academia and the NHS, involving patients in research. It is also a partnership between funders: the NIHR and Wellcome. And it is a partnership between NHS trusts working together as part of King’s Health Partners Academic Health Sciences Centre. SLaM, the crown jewel of mental health in Britain, working with King’s College Hospital so that patients will benefit from being at an acute hospital. SLaM and the IoP are leaders in psychiatry research, and this facility will be key to tackling the disease burden in psychiatry.”

Professor Peter Goadsby, Director of the NIHR/Wellcome King’s CRF, said: “The CRF is a unique facility combining basic science and translational medicine. By bringing together our experimental medicine facility with our clinical trials unit under one roof, we can enable studies to move from bench to bedside, providing real prospects for improving patient care.”

The CRF includes:

• An Experimental Medicine Facility (EMF) including the latest neuro-imaging and EEG facilities, a virtual reality suite and an intensive care unit facility for patients with brain injury;
• The largest Cell Therapy Unit (CTU) in Europe in either academia or industry, with capacity to produce up to 1,000 therapies per year;
• A Clinical Trials Unit (CTU) providing a state of the art facility for commercially sponsored trials.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Stem Cell Therapy For Inherited Skin Blistering
Study shows promise for using stem-cell based therapy to treat RDEB.
Tuesday, May 26, 2015
Eating Peanut at an Early Age Prevents Peanut Allergy in High-Risk Infants
New evidence shows that the majority of infants at high-risk of developing peanut allergy are protected from peanut allergy at age 5 years if they eat peanut frequently, starting within the first 11 months of life.
Tuesday, February 24, 2015
Epigenetic Study Bolsters Alzheimer's Understanding
The current study found that chemical modifications to DNA within the ANK1 gene are strongly associated with measures of neuropathology in the brain.
Monday, August 18, 2014
Significant Step Towards Blood Test for Alzheimer's
Scientists have identified a set of 10 proteins in the blood which can predict the onset of Alzheimer’s, marking a significant step towards developing a blood test for the disease.
Tuesday, July 08, 2014
Key Genetic Link Between Chronic Pain Conditions Discovered
Research from at King’s College London suggests that some people may be genetically predisposed to suffer from conditions of this type.
Wednesday, May 21, 2014
Skin Layer Grown in Lab Could Replace Animal Testing
Skin layer grown from human stem cells could replace animals in drug and cosmetics testing.
Monday, April 28, 2014
Strong Link Between Obesity and 'Carb Breakdown' Gene
Findings suggest that dietary advice may need to be tailored to individual's digestive system.
Monday, March 31, 2014
Scientific News
Food Triggers Creation of Regulatory T Cells
IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.
Light Signals from Living Cells
Fluorescent protein markers delivered under high pressure.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Cellular 'Relief Valve'
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.
Genomic Signature Shared by Five Types of Cancer
National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer.
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Genetic Cause of Rare Allergy
Institute has identified a genetic mutation responsible for a rare form of inherited hives induced by vibratory urticaria.
Battery Component Found to Harm Key Soil Microorganism
The material at the heart of the lithium ion batteries that power electric vehicles, laptop computers and smartphones has been shown to impair a key soil bacterium, according to new research.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!